Cagrilintide vs MOTS-C
Cagrilintide and MOTS-C are both studied in weight research, but they are different classes of compound with different reported research applications.
✓ both US-made · third-party tested · batch COA on every order
Last updated August 25, 2026
How do Cagrilintide and MOTS-C differ?
Cagrilintide (Long-acting amylin analog peptide) is catalogued under weight & metabolic research; MOTS-C (Mitochondrial-derived 16-amino-acid peptide) is catalogued under weight & metabolic research. Verve lists 5 reported research applications for Cagrilintide and 5 for MOTS-C. Both are made in the United States, screened by HPLC to a 99%+ purity standard, and shipped with a batch-level certificate of analysis.
| field | Cagrilintide | MOTS-C |
|---|---|---|
| compound class | Long-acting amylin analog peptide | Mitochondrial-derived 16-amino-acid peptide |
| research area | weight & metabolic | weight & metabolic |
| reported research applications | 5 listed | 5 listed |
| supplied as | single compound | single compound |
| catalog sizes | 10mg | 10mg |
| purity standard | 99%+ by HPLC | 99%+ by HPLC |
| manufactured | United States | United States |
| batch COA | published per lot | published per lot |
| endotoxin-tested option | not offered | available |
| co-formulated together in | not co-formulated | not co-formulated |
| price from | $157.49 | $78.99 |
| availability | out of stock | in stock |
Prices and stock read live from the catalog. Both compounds are supplied strictly as reference materials for in-vitro laboratory research.
What is Cagrilintide and what is MOTS-C?
Cagrilintide is classified as Long-acting amylin analog peptide; MOTS-C as Mitochondrial-derived 16-amino-acid peptide. Both profiles below cover scientific identity only — what the molecule is and which laboratory models it appears in. Verve supplies both strictly as in-vitro reference materials, and neither profile describes human or veterinary use.
Cagrilintide
Long-acting amylin analog peptide
Cagrilintide is a synthetic long-acting analog of amylin, the pancreatic peptide co-secreted with insulin from beta cells. Its sequence is engineered for solubility and resistance to aggregation, and it carries a fatty-acid side chain that extends circulating half-life in pre-clinical systems, giving researchers a stable tool compound where native amylin is notoriously difficult to work with.
full Cagrilintide profile →MOTS-C
Mitochondrial-derived 16-amino-acid peptide
MOTS-c is a 16-amino-acid peptide encoded not by nuclear DNA but by a short open reading frame within the mitochondrial 12S rRNA gene. It belongs to the mitochondrial-derived peptide family, a group of small peptides that are of interest in research precisely because their genetic origin sits inside the organelle rather than the nucleus.
full MOTS-C profile →Which research models is each compound studied in?
Cagrilintide and MOTS-C both sit inside weight & metabolic research, so their listed models share framing while differing in specifics. The table lists 5 reported research applications for Cagrilintide and 5 for MOTS-C. Rows are per compound, not equivalences.
| Cagrilintide — reported research applications | MOTS-C — reported research applications |
|---|---|
| Amylin- and calcitonin-receptor agonism research | Mitochondrial-derived peptide and retrograde-signaling research |
| Calcitonin-receptor / RAMP complex pharmacology studies | AMPK pathway research models |
| Peptide aggregation, solubility, and stability research | One-carbon (folate–methionine) metabolism studies |
| Metabolic-signaling research models | Cellular energy-metabolism and substrate-utilization research |
| Comparative studies alongside incretin-receptor reference compounds | Exercise-physiology and metabolic-stress research models |
Research contexts only. Both compounds are supplied for laboratory research use only, and no entry above describes an effect in humans or animals.
What sizes and prices does verve list for Cagrilintide and MOTS-C?
Cagrilintide is listed from $157.49 and MOTS-C from $78.99. The table below is every catalog size verve currently lists for the two compounds, at single-vial prices before the automatic multi-compound discount. Sizes describe the vial format supplied to the laboratory, nothing more.
| compound | size listed | price | availability |
|---|---|---|---|
| Cagrilintide | 10mg | $157.49 | out of stock |
| MOTS-C | 10mg | $78.99 | in stock |
Any 2 different compounds take 20% off, any 3 take 30% — applied automatically in the cart, no code. Orders placed Monday–Friday ship by 2pm CT, free over $100.
shop the compounds →Frequently asked questions about Cagrilintide and MOTS-C
What is Cagrilintide?
Cagrilintide is a synthetic long-acting analog of the pancreatic peptide amylin, engineered for stability and extended half-life. Verve supplies it as a research compound for laboratory use only, not for human or veterinary use.
What is Cagrilintide studied for in research?
It is used as a reference agonist in amylin- and calcitonin-receptor pharmacology, RAMP-complex research, and metabolic-signaling models in vitro and pre-clinically. Verve makes no health claims.
What is MOTS-C?
MOTS-c is a 16-amino-acid peptide encoded by a short open reading frame in the mitochondrial genome. Verve supplies it as a research compound for laboratory use only, not for human or veterinary use.
What is MOTS-C studied for in research?
It is used in mitochondrial-signaling research, including AMPK pathway activity, one-carbon metabolism, and retrograde signaling between mitochondria and the nucleus in in-vitro and pre-clinical models. Verve makes no health claims.
related comparisons
verve products are sold for laboratory research and development purposes only and are not intended for human or veterinary use of any kind. statements on this site have not been evaluated by the FDA.